Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000.

Pihlajamäki M, Jalava J, Huovinen P, Kotilainen P; Finnish Study Group for Antimicrobial Resistance.

Antimicrob Agents Chemother. 2003 Jun;47(6):1832-5.

2.

Macrolide resistance in Streptococcus pneumoniae: clonality and mechanisms of resistance in 24 countries.

Bozdogan B, Bogdanovich T, Kosowska K, Jacobs MR, Appelbaum PC.

Curr Drug Targets Infect Disord. 2004 Sep;4(3):169-76. Review.

PMID:
15379728
3.

The antimicrobial resistance profile of Streptococcus pneumoniae.

Reinert RR.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:7-11. doi: 10.1111/j.1469-0691.2009.02724.x. Review.

4.

Resistance among Streptococcus pneumoniae: Implications for drug selection.

Appelbaum PC.

Clin Infect Dis. 2002 Jun 15;34(12):1613-20. Epub 2002 May 16. Review.

PMID:
12032897
5.

Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia.

Lynch III JP, Martinez FJ.

Clin Infect Dis. 2002 Mar 1;34 Suppl 1:S27-46. Review.

PMID:
11810608
6.
7.

Macrolide Resistance in Streptococcus pneumoniae.

Schroeder MR, Stephens DS.

Front Cell Infect Microbiol. 2016 Sep 21;6:98. eCollection 2016. Review.

8.

[Beta-lactam and macrolide resistance in Streptococcus pneumoniae].

Shibasaki Y, Ubukata K.

Nihon Rinsho. 2001 Apr;59(4):681-6. Review. Japanese.

PMID:
11304989
9.

Pneumococcal drug resistance: the new "special enemy of old age".

Butler JC, Cetron MS.

Clin Infect Dis. 1999 Apr;28(4):730-5. Review.

PMID:
10825028
10.

Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Leclercq R.

Clin Infect Dis. 2002 Feb 15;34(4):482-92. Epub 2002 Jan 11. Review.

PMID:
11797175
11.

Resistance to Macrolide Antibiotics in Public Health Pathogens.

Fyfe C, Grossman TH, Kerstein K, Sutcliffe J.

Cold Spring Harb Perspect Med. 2016 Oct 3;6(10). pii: a025395. doi: 10.1101/cshperspect.a025395. Review.

PMID:
27527699
12.

Macrolide antibiotics: binding site, mechanism of action, resistance.

Gaynor M, Mankin AS.

Curr Top Med Chem. 2003;3(9):949-61. Review.

PMID:
12678831
13.

Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E).

Klaassen CH, Mouton JW.

Antimicrob Agents Chemother. 2005 Apr;49(4):1271-8. Review. No abstract available.

14.

[Multiresistance microbes and antimicrobial antibiotic policy in Finland].

Huovinen P, Valtonen V.

Duodecim. 1996;112(10):883-8. Review. Finnish. No abstract available.

PMID:
10592979
15.

New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae.

Tomasz A.

Am J Med. 1999 Jul 26;107(1A):55S-62S. Review. No abstract available.

PMID:
10451010
16.

Symposium on antimicrobial therapy. IX. The glycopeptide and macrolide antibiotics.

Greenfield RA.

J Okla State Med Assoc. 1993 Jun;86(6):269-75. Review. No abstract available.

PMID:
8326418
17.

Reevaluation of antibiotic breakpoints.

Phillips I.

Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S230-2. Review.

PMID:
11519009
18.

[Mechanisms of macrolide resistance in organisms producing them and in eubacteria].

Sazykin IuO, Shvets AV, Ivanov VP.

Antibiot Khimioter. 1998;43(6):32-40. Review. Russian. No abstract available.

PMID:
9644533

Supplemental Content

Support Center